PUBLISHER: BCC Research | PRODUCT CODE: 1338268
PUBLISHER: BCC Research | PRODUCT CODE: 1338268
The global market for precision medicine is estimated to increase from $54.2 billion in 2023 to reach $100.5 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.
North American market for precision medicine is estimated to increase from $22.6 billion in 2023 to reach $42.1 billion by 2028, at a compound annual growth rate (CAGR) of 13.2% from 2023 through 2028.
European market for precision medicine is estimated to increase from $14.1 billion in 2023 to reach $26.4 billion by 2028, at a compound annual growth rate (CAGR) of 13.4% from 2023 through 2028.
This study offers a global view of the solutions provided by precision medicine in the market. This report analyzes and assesses technologies such as big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. It also provides information about the areas in which precision medicine is used, such as oncology, central nervous system disorders, immunology, respiratory conditions, and others.
BCC Research analyzes and makes projections for each market and its segmentation and assesses the regulatory environment, pipeline products, and future aspects. The report also examines the impact of COVID, discusses emerging trends in the market, and profiles leading companies in the precision medicine market such as Pfizer, Roche, AstraZeneca, Novartis, and Thermo Fisher Scientific. The report covers the major markets of North America and Europe and emerging markets such as India, China, Japan, South America, and others.